New data on using the nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone to treat patients with type 2 diabetes and chronic […]
Dulaglutide Tied to Lower Incidence of Erectile Dysfunction in Type 2 Diabetes
NEW YORK (Reuters Health) – Men with type 2 diabetes randomly assigned to dulaglutide versus placebo had a lower incidence […]